Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer.

Nuzzo S, Roscigno G, Affinito A, Ingenito F, Quintavalle C, Condorelli G.

Cancers (Basel). 2019 Oct 10;11(10). pii: E1521. doi: 10.3390/cancers11101521. Review.

2.

The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.

Ingenito F, Roscigno G, Affinito A, Nuzzo S, Scognamiglio I, Quintavalle C, Condorelli G.

Int J Mol Sci. 2019 Sep 21;20(19). pii: E4687. doi: 10.3390/ijms20194687. Review.

3.

The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.

Affinito A, Quintavalle C, Esposito CL, Roscigno G, Vilardo C, Nuzzo S, Ricci-Vitiani L, De Luca G, Pallini R, Kichkailo AS, Lapin IN, de Franciscis V, Condorelli G.

Mol Ther Nucleic Acids. 2019 Dec 6;18:99-109. doi: 10.1016/j.omtn.2019.08.015. Epub 2019 Aug 22.

4.

Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine.

Scialabba C, Sciortino A, Messina F, Buscarino G, Cannas M, Roscigno G, Condorelli G, Cavallaro G, Giammona G, Mauro N.

ACS Appl Mater Interfaces. 2019 Jun 5;11(22):19854-19866. doi: 10.1021/acsami.9b04925. Epub 2019 May 24.

PMID:
31088077
5.

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.

Russo V, Paciocco A, Affinito A, Roscigno G, Fiore D, Palma F, Galasso M, Volinia S, Fiorelli A, Esposito CL, Nuzzo S, Inghirami G, de Franciscis V, Condorelli G.

Mol Ther Nucleic Acids. 2018 Dec 7;13:334-346. doi: 10.1016/j.omtn.2018.09.016. Epub 2018 Sep 27.

6.

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.

Ng CKY, Di Costanzo GG, Tosti N, Paradiso V, Coto-Llerena M, Roscigno G, Perrina V, Quintavalle C, Boldanova T, Wieland S, Marino-Marsilia G, Lanzafame M, Quagliata L, Condorelli G, Matter MS, Tortora R, Heim MH, Terracciano LM, Piscuoglio S.

Ann Oncol. 2018 May 1;29(5):1286-1291. doi: 10.1093/annonc/mdy083.

7.

Informational and linguistic analysis of large genomic sequence collections via efficient Hadoop cluster algorithms.

Ferraro Petrillo U, Roscigno G, Cattaneo G, Giancarlo R.

Bioinformatics. 2018 Jun 1;34(11):1826-1833. doi: 10.1093/bioinformatics/bty018.

PMID:
29342232
8.

Oil distillation wastewaters from aromatic herbs as new natural source of antioxidant compounds.

Celano R, Piccinelli AL, Pagano I, Roscigno G, Campone L, De Falco E, Russo M, Rastrelli L.

Food Res Int. 2017 Sep;99(Pt 1):298-307. doi: 10.1016/j.foodres.2017.05.036. Epub 2017 May 30.

PMID:
28784486
9.

Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.

Briguori C, Quintavalle C, D'Alessio F, Donahue M, Roscigno G, De Micco F, Focaccio A, Visconti G, Del Vecchio L, Madonna R, De Caterina R, Condorelli G.

Int J Cardiol. 2017 Oct 1;244:112-118. doi: 10.1016/j.ijcard.2017.06.087. Epub 2017 Jun 27.

PMID:
28668399
10.

Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.

Donnarumma E, Fiore D, Nappa M, Roscigno G, Adamo A, Iaboni M, Russo V, Affinito A, Puoti I, Quintavalle C, Rienzo A, Piscuoglio S, Thomas R, Condorelli G.

Oncotarget. 2017 Mar 21;8(12):19592-19608. doi: 10.18632/oncotarget.14752.

11.

FASTdoop: a versatile and efficient library for the input of FASTA and FASTQ files for MapReduce Hadoop bioinformatics applications.

Ferraro Petrillo U, Roscigno G, Cattaneo G, Giancarlo R.

Bioinformatics. 2017 May 15;33(10):1575-1577. doi: 10.1093/bioinformatics/btx010.

PMID:
28093410
12.

RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.

Adamo A, Fiore D, De Martino F, Roscigno G, Affinito A, Donnarumma E, Puoti I, Ricci Vitiani L, Pallini R, Quintavalle C, Condorelli G.

Oncotarget. 2017 Feb 21;8(8):13476-13487. doi: 10.18632/oncotarget.14564.

13.

MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.

Roscigno G, Puoti I, Giordano I, Donnarumma E, Russo V, Affinito A, Adamo A, Quintavalle C, Todaro M, Vivanco MD, Condorelli G.

Oncotarget. 2017 Mar 21;8(12):19507-19521. doi: 10.18632/oncotarget.14470.

14.

Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor.

Voccia D, Sosnowska M, Bettazzi F, Roscigno G, Fratini E, De Franciscis V, Condorelli G, Chitta R, D'Souza F, Kutner W, Palchetti I.

Biosens Bioelectron. 2017 Jan 15;87:1012-1019. doi: 10.1016/j.bios.2016.09.058. Epub 2016 Sep 17.

PMID:
27686606
15.

Essential-Oil Variability in a Collection of Ocimum basilicum L. (Basil) Cultivars.

Maggio A, Roscigno G, Bruno M, De Falco E, Senatore F.

Chem Biodivers. 2016 Oct;13(10):1357-1368. doi: 10.1002/cbdv.201600069.

PMID:
27444992
16.

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.

Iaboni M, Russo V, Fontanella R, Roscigno G, Fiore D, Donnarumma E, Esposito CL, Quintavalle C, Giangrande PH, de Franciscis V, Condorelli G.

Mol Ther Nucleic Acids. 2016 Mar 8;5:e289. doi: 10.1038/mtna.2016.5.

17.

miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.

Fiore D, Donnarumma E, Roscigno G, Iaboni M, Russo V, Affinito A, Adamo A, De Martino F, Quintavalle C, Romano G, Greco A, Soini Y, Brunetti A, Croce CM, Condorelli G.

Oncotarget. 2016 Apr 12;7(15):19531-47. doi: 10.18632/oncotarget.6968.

18.

MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.

Roscigno G, Quintavalle C, Donnarumma E, Puoti I, Diaz-Lagares A, Iaboni M, Fiore D, Russo V, Todaro M, Romano G, Thomas R, Cortino G, Gaggianesi M, Esteller M, Croce CM, Condorelli G.

Oncotarget. 2016 Jan 5;7(1):580-92. doi: 10.18632/oncotarget.5979.

19.

Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.

Quintavalle C, Anselmi CV, De Micco F, Roscigno G, Visconti G, Golia B, Focaccio A, Ricciardelli B, Perna E, Papa L, Donnarumma E, Condorelli G, Briguori C.

Circ Cardiovasc Interv. 2015 Sep;8(9):e002673. doi: 10.1161/CIRCINTERVENTIONS.115.002673. Erratum in: Circ Cardiovasc Interv. 2015 Oct;8(10):e000015.

PMID:
26333343
20.

Chemical composition and biological activity of essential oils of Origanum vulgare L. subsp. vulgare L. under different growth conditions.

De Falco E, Mancini E, Roscigno G, Mignola E, Taglialatela-Scafati O, Senatore F.

Molecules. 2013 Dec 4;18(12):14948-60. doi: 10.3390/molecules181214948.

21.

Phytomorphological and essential-oil characterization in situ and ex situ of wild biotypes of oregano collected in the Campania region (Southern Italy).

De Falco E, Roscigno G, Iodice C, Senatore F.

Chem Biodivers. 2013 Nov;10(11):2078-90. doi: 10.1002/cbdv.201300185.

PMID:
24243616
22.

MiR-221/222 target the DNA methyltransferase MGMT in glioma cells.

Quintavalle C, Mangani D, Roscigno G, Romano G, Diaz-Lagares A, Iaboni M, Donnarumma E, Fiore D, De Marinis P, Soini Y, Esteller M, Condorelli G.

PLoS One. 2013 Sep 19;8(9):e74466. doi: 10.1371/journal.pone.0074466. eCollection 2013.

23.

Chemical composition, antimicrobial and antioxidant activities of anethole-rich oil from leaves of selected varieties of fennel [Foeniculum vulgare Mill. ssp. vulgare var. azoricum (Mill.) Thell].

Senatore F, Oliviero F, Scandolera E, Taglialatela-Scafati O, Roscigno G, Zaccardelli M, De Falco E.

Fitoterapia. 2013 Oct;90:214-9. doi: 10.1016/j.fitote.2013.07.021. Epub 2013 Aug 9.

PMID:
23933237
24.

Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.

Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli G.

Oncogene. 2013 Aug 22;32(34):4001-8. doi: 10.1038/onc.2012.410. Epub 2012 Sep 10.

PMID:
22964638
25.

Global health: Integrating national laboratory health systems and services in resource-limited settings.

Parsons LM, Somoskovi A, Lee E, Paramasivan CN, Schneidman M, Birx D, Roscigno G, Nkengasong J.

Afr J Lab Med. 2012 Jun 11;1(1):11. doi: 10.4102/ajlm.v1i1.11. eCollection 2012.

26.

A dominant mutation etiologic for human tricho-dento-osseous syndrome impairs the ability of DLX3 to downregulate ΔNp63α.

Di Costanzo A, Festa L, Roscigno G, Vivo M, Pollice A, Morasso M, La Mantia G, Calabrò V.

J Cell Physiol. 2011 Aug;226(8):2189-97. doi: 10.1002/jcp.22553.

PMID:
21520071
27.

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Parsons LM, Somoskövi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, Spector S, Roscigno G, Nkengasong J.

Clin Microbiol Rev. 2011 Apr;24(2):314-50. doi: 10.1128/CMR.00059-10. Review.

28.

Laboratory systems and services are critical in global health: time to end the neglect?

Nkengasong JN, Nsubuga P, Nwanyanwu O, Gershy-Damet GM, Roscigno G, Bulterys M, Schoub B, DeCock KM, Birx D.

Am J Clin Pathol. 2010 Sep;134(3):368-73. doi: 10.1309/AJCPMPSINQ9BRMU6.

PMID:
20716791
29.

"Piggy-backing" on diagnostic platforms brings hope to neglected diseases: the case of sleeping sickness.

Ndung'u JM, Bieler S, Roscigno G.

PLoS Negl Trop Dis. 2010 May 25;4(5):e715. doi: 10.1371/journal.pntd.0000715. No abstract available.

30.

Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.

Zvada SP, Van Der Walt JS, Smith PJ, Fourie PB, Roscigno G, Mitchison D, Simonsson US, McIlleron HM.

Antimicrob Agents Chemother. 2010 Aug;54(8):3390-4. doi: 10.1128/AAC.00345-10. Epub 2010 Jun 1.

31.

Chemical composition and antigerminative activity of the essential oils from five Salvia species.

De Martino L, Roscigno G, Mancini E, De Falco E, De Feo V.

Molecules. 2010 Feb 1;15(2):735-46. doi: 10.3390/molecules15020735.

32.

Experience establishing tuberculosis laboratory capacity in a developing country setting.

Paramasivan CN, Lee E, Kao K, Mareka M, Kubendiran G, Kumar TA, Keshavjee S, Satti H, Alabi G, Raviglione M, Roscigno G.

Int J Tuberc Lung Dis. 2010 Jan;14(1):59-64.

PMID:
20003696
33.

Progress towards improved tuberculosis diagnostics for developing countries.

Perkins MD, Roscigno G, Zumla A.

Lancet. 2006 Mar 18;367(9514):942-3. No abstract available.

PMID:
16546544
34.

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.

Sirgel FA, Fourie PB, Donald PR, Padayatchi N, Rustomjee R, Levin J, Roscigno G, Norman J, McIlleron H, Mitchison DA.

Am J Respir Crit Care Med. 2005 Jul 1;172(1):128-35. Epub 2005 Apr 1.

PMID:
15805182
35.

Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.

Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Sateesh K, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P, Moore T.

Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):703-21. Review.

PMID:
15632956
36.

In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infections.

Lounis N, Roscigno G.

Curr Pharm Des. 2004;10(26):3229-38. Review.

PMID:
15544512
37.

Giorgio Roscigno--senior advisor to the Global Alliance for TB Drug Development. Interviewed by Pam Das.

Roscigno G.

Lancet Infect Dis. 2002 Jun;2(6):377-80. No abstract available.

PMID:
12144902
38.

Joining forces to develop weapons against TB: together we must.

Freire M, Roscigno G.

Bull World Health Organ. 2002;80(6):429. No abstract available.

39.

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.

Lounis N, Bentoucha A, Truffot-Pernot C, Ji B, O'Brien RJ, Vernon A, Roscigno G, Grosset J.

Antimicrob Agents Chemother. 2001 Dec;45(12):3482-6.

40.

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

Ji B, Truffot-Pernot C, Lacroix C, Raviglione MC, O'Brien RJ, Olliaro P, Roscigno G, Grosset J.

Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1541-6.

PMID:
8256897
41.

Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.

Wolde K, Lema E, Roscigno G, Abdi A.

Ethiop Med J. 1992 Apr;30(2):63-8.

PMID:
1345030
42.

Reversal of chloroquine resistance of 'wild' isolates of Plasmodium falciparum by desipramine.

Carosi G, Caligaris S, Fadat G, Castelli F, Matteelli A, Kouka-Bemba D, Roscigno G.

Trans R Soc Trop Med Hyg. 1991 Nov-Dec;85(6):723-4. No abstract available.

PMID:
1801334
43.

Late-stage African trypanosomiasis and eflornithine.

di Bari C, Pastore G, Roscigno G, Schechter PJ, Sjoerdsma A.

Ann Intern Med. 1986 Nov;105(5):803-4. No abstract available.

PMID:
3094420

Supplemental Content

Loading ...
Support Center